Date | Author | Type | Reco Price | Target Price | Potential | Source | PDF Link |
---|---|---|---|---|---|---|---|
23 May 2025 | ICICI Securities | Buy | ₹133.22 | ₹161 | 20.1% | moneycontrol | View |
15 May 2025 | ICICI Securities | Buy | ₹132.88 | ₹161 | 19.1% | moneycontrol | View |
14 Feb 2025 | ICICI Securities | Buy | ₹133.15 | ₹157 | 17.8% | moneycontrol | View |
Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
---|---|---|---|---|---|---|
INVESCO India Gold Exchange Tr | NA | NA | NA | NA | 0 | |
MOTILAL OSWAL MOST SHARES NASD | NA | NA | NA | NA | 0 | |
Nexus Select Trust | NA | NA | NA | NA | 24,952 | 53.9 |
Emcure Pharmaceuticals Limited | 11180.97 | 1227.89 | 10965.73 | 6.48 | 24337 | 32.3 |
Aadhar Housing Finance Limited | 8513.4 | 2372.8 | 8481.8 | 5.37 | 22168 | 23.4 |
Nexus Select Trust has established itself in the None sector, offering a range of products and services that cater to its market. With a strong presence in its field, the company is committed to growth and innovation in the industry.
No Standalone or Consolidated data available.
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | -4% |
3 Years: | 0% |
TTM: | 23% |
Compounded Profit Growth | |
---|---|
10 Years: | 0% |
5 Years: | 39% |
3 Years: | 358% |
TTM: | 20% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
1 Year: | 9% |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | 20% |
Compounded Profit Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | -13% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
1 Year: | 9% |
Recent Bets
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
---|
News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
---|---|---|---|---|---|---|
Loading company updates… |
Period | SMA Value | Status |
---|
Period | EMA Value | Status |
---|
Indicator | Value |
---|